Companies

ArriVent BioPharma, Inc. (AVBP) SEC filings

CIK 0001868279 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024
Net income (USD)-166.3 M-69.3 M
Diluted EPS (USD/shares)-4.32-32.38

Latest filings

FiledFormDescriptionPeriod
2026-10-198-KFORM 8-K items 7.01,9.012026-10-19
2026-10-13SCHEDULE 13GSCHEDULE 13G
2026-10-138-KFORM 8-K items 7.01,8.01,9.012026-10-12
2026-10-08SCHEDULE 13D/ASCHEDULE 13D/A
2026-10-068-KFORM 8-K items 7.01,8.01,9.012026-10-06
2026-08-1210-Q10-Q2026-06-30
2026-08-128-KFORM 8-K items 1.01,2.02,9.012026-08-11
2026-07-27SCHEDULE 13G/ASCHEDULE 13G/A
2026-06-224OWNERSHIP DOCUMENT2026-06-18
2026-06-224OWNERSHIP DOCUMENT2026-06-18
2026-06-224OWNERSHIP DOCUMENT2026-06-18
2026-06-224OWNERSHIP DOCUMENT2026-06-18
2026-06-228-KFORM 8-K items 5.072026-06-18
2026-05-118-KFORM 8-K items 8.01,9.012026-05-11
2026-05-11424B5424B5
2026-05-1110-Q10-Q2026-03-31
2026-05-118-K8-K items 2.02,9.012026-05-11
2026-05-06SCHEDULE 13G/ASCHEDULE 13G/A
2026-04-28ARSARS2025-12-31
2026-04-28DEFA14ADEFA14A
2026-04-28DEF 14AFORM- DEF 14A2026-06-18
2026-03-178-K8-K items 7.01,8.01,9.012026-03-17
2026-03-05S-8FORM S-8
2026-03-0510-K10-K2025-12-31
2026-03-058-K8-K items 2.02,9.012026-03-05

Forms on file (last 1,000): 4 30, 8-K 30, 3 14, SCHEDULE 13G/A 11, 10-Q 8, SC 13G 8, SCHEDULE 13G 7, CORRESP 4. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=AVBP (0.002 USD), /gw/filings/filings?ticker=AVBP&form=8-K, /gw/filings/facts?ticker=AVBP&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange